These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36177952)

  • 1. Positive association between research competitiveness of Chinese academic hospitals and the scale of their biobanks: A national survey.
    Zhang Y; Bian Z; Chen Y; Jiang E; Chen T; Wang C
    Clin Transl Sci; 2022 Dec; 15(12):2909-2917. PubMed ID: 36177952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Scale, Collections, and Biospecimen Distribution of Grade A Tertiary Hospital Biobanks in China: A National Survey.
    Chen Y; Sang C; Bian Z; Zhang Y; Jiang E; Zhou X; Chen T; Tang H; Wang C
    Front Med (Lausanne); 2020; 7():560600. PubMed ID: 33537321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of the Current Situation of Clinical Biobanks in China.
    Li H; Ni M; Wang P; Wang X
    Biopreserv Biobank; 2017 Jun; 15(3):248-252. PubMed ID: 28080144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese biobanks: present and future.
    Cheng L; Shi C; Wang X; Li Q; Wan Q; Yan Z; Zhang Y
    Genet Res (Camb); 2013 Dec; 95(6):157-64. PubMed ID: 24629460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific research competitiveness in hospitals: A narrative review of major hospital ranking systems in China.
    Li D; Yu J; Lv ZW; Gu WJ; Li JY
    Health Sci Rep; 2022 May; 5(3):e583. PubMed ID: 35509381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners.
    Baber R; Hummel M; Jahns R; von Jagwitz-Biegnitz M; Kirsten R; Klingler C; Nussbeck SY; Specht C
    Biopreserv Biobank; 2019 Aug; 17(4):372-374. PubMed ID: 31314575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A European survey on biobanks: trends and issues.
    Zika E; Paci D; Braun A; Rijkers-Defrasne S; Deschênes M; Fortier I; Laage-Hellman J; Scerri CA; Ibarreta D
    Public Health Genomics; 2011; 14(2):96-103. PubMed ID: 20395653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biobank classification in an Australian setting.
    Rush A; Christiansen JH; Farrell JP; Goode SM; Scott RJ; Spring KJ; Byrne JA
    Biopreserv Biobank; 2015 Jun; 13(3):212-8. PubMed ID: 26035012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biobanks in the low- and middle-income countries of the Arab Middle East region: challenges, ethical issues, and governance arrangements-a qualitative study involving biobank managers.
    Abdelhafiz AS; Ahram M; Ibrahim ME; Elgamri A; Gamel E; Labib R; Silverman H
    BMC Med Ethics; 2022 Aug; 23(1):83. PubMed ID: 35965314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Approach to Evaluate the Costs and Outputs of Academic Biobanks.
    Rush A; ; Catchpoole DR; Watson PH; Byrne JA
    Biopreserv Biobank; 2024 Oct; 22(5):463-474. PubMed ID: 38666406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategic plan for the second phase (2013-2015) of the Korea biobank project.
    Park O; Cho SY; Shin SY; Park JS; Kim JW; Han BG
    Osong Public Health Res Perspect; 2013 Apr; 4(2):107-16. PubMed ID: 24159540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing biobank organizations in the U.S.: results from a national survey.
    Henderson GE; Cadigan RJ; Edwards TP; Conlon I; Nelson AG; Evans JP; Davis AM; Zimmer C; Weiner BJ
    Genome Med; 2013; 5(1):3. PubMed ID: 23351549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019; 17(1):71-75. PubMed ID: 30412417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a business model to assure financial sustainability of biobanks.
    Warth R; Perren A
    Biopreserv Biobank; 2014 Dec; 12(6):389-94. PubMed ID: 25496150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey.
    Rush A; Catchpoole DR; Reaiche-Miller G; Gilbert T; Ng W; Watson PH; Byrne JA
    Biopreserv Biobank; 2022 Jun; 20(3):271-282. PubMed ID: 34756100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.